People: Developer Of Recombinant BCG Vaccine Wins Infectious Disease Research Award

Barry R. Bloom, an immunologist at the Albert Einstein College of Medicine in New York and an investigator with the Howard Hughes Medical Institute, last month received the first annual Bristol- Myers Squibb Award for Distinguished Achievement in Infectious Disease Research. The $50,000 cash prize was given in recognition of Bloom's contributions to immunology, including the development of an experimental recombinant multiple vaccine and investigations of leprosy and tuberculosis. Throughout

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Throughout most of his career, Bloom's research has focused on health problems in developing countries. But this was not always the case. "I started out revolted by applied science," recalls Bloom. "I was going to be the most basic" of basic researchers. He changed his mind about the value of applied research on a trip to India in 1968, where, he says, "I gained perspective on the world, and what my training in medical research could do."

One aspect of this focus is the development of a multipurpose vaccine created by genetically engineering the bacillus BCG (bacille Calmette-Gurin). BCG, used to protect against tuberculosis, is the oldest and most widely used vaccine in the world. Bloom's lab, along with collaborators at the University of Pittsburgh and MedImmune Inc. of Gaithersburg, Md., have developed a method of introducing protective antigens for a variety of diseases into BCG, so that this vaccine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Rebecca Andrews

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo